Medical Care
Global Predictive Presymptomatic Testing Market Research Report 2025
- Jul 08, 25
- ID: 347716
- Pages: 73
- Figures: 76
- Views: 47
The global market for Predictive Presymptomatic Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Predictive Presymptomatic Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Predictive Presymptomatic Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Predictive Presymptomatic Testing in Breast and Ovarian Cancer is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Predictive Presymptomatic Testing include 23andMe, Inc., Abbott Laboratories, Bayer HealthCare AG, Biocartis SA, BioHelix Corporation, bioMerieux S.A., Celera Corporation (Quest Diagnostics), Cepheid (Danaher), Daan Diagnostics Ltd., EKF Diagnostics Holdings plc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Predictive Presymptomatic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Predictive Presymptomatic Testing.
The Predictive Presymptomatic Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Predictive Presymptomatic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Predictive Presymptomatic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
23andMe, Inc.
Abbott Laboratories
Bayer HealthCare AG
Biocartis SA
BioHelix Corporation
bioMerieux S.A.
Celera Corporation (Quest Diagnostics)
Cepheid (Danaher)
Daan Diagnostics Ltd.
EKF Diagnostics Holdings plc
Segment by Type
Molecular Testing
Cytogenic Testing
Biochemical Testing
Segment by Application
Breast and Ovarian Cancer
Colorectal Cancer
Alzheimer's Disease
Multiple Endocrine Neoplasia Type 2
Haemochromatosis
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Predictive Presymptomatic Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
North American market for Predictive Presymptomatic Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Predictive Presymptomatic Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Predictive Presymptomatic Testing in Breast and Ovarian Cancer is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Predictive Presymptomatic Testing include 23andMe, Inc., Abbott Laboratories, Bayer HealthCare AG, Biocartis SA, BioHelix Corporation, bioMerieux S.A., Celera Corporation (Quest Diagnostics), Cepheid (Danaher), Daan Diagnostics Ltd., EKF Diagnostics Holdings plc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Predictive Presymptomatic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Predictive Presymptomatic Testing.
The Predictive Presymptomatic Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Predictive Presymptomatic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Predictive Presymptomatic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
23andMe, Inc.
Abbott Laboratories
Bayer HealthCare AG
Biocartis SA
BioHelix Corporation
bioMerieux S.A.
Celera Corporation (Quest Diagnostics)
Cepheid (Danaher)
Daan Diagnostics Ltd.
EKF Diagnostics Holdings plc
Segment by Type
Molecular Testing
Cytogenic Testing
Biochemical Testing
Segment by Application
Breast and Ovarian Cancer
Colorectal Cancer
Alzheimer's Disease
Multiple Endocrine Neoplasia Type 2
Haemochromatosis
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Predictive Presymptomatic Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Predictive Presymptomatic Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Molecular Testing
1.2.3 Cytogenic Testing
1.2.4 Biochemical Testing
1.3 Market by Application
1.3.1 Global Predictive Presymptomatic Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Breast and Ovarian Cancer
1.3.3 Colorectal Cancer
1.3.4 Alzheimer's Disease
1.3.5 Multiple Endocrine Neoplasia Type 2
1.3.6 Haemochromatosis
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Predictive Presymptomatic Testing Market Perspective (2020-2031)
2.2 Global Predictive Presymptomatic Testing Growth Trends by Region
2.2.1 Global Predictive Presymptomatic Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Predictive Presymptomatic Testing Historic Market Size by Region (2020-2025)
2.2.3 Predictive Presymptomatic Testing Forecasted Market Size by Region (2026-2031)
2.3 Predictive Presymptomatic Testing Market Dynamics
2.3.1 Predictive Presymptomatic Testing Industry Trends
2.3.2 Predictive Presymptomatic Testing Market Drivers
2.3.3 Predictive Presymptomatic Testing Market Challenges
2.3.4 Predictive Presymptomatic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Predictive Presymptomatic Testing Players by Revenue
3.1.1 Global Top Predictive Presymptomatic Testing Players by Revenue (2020-2025)
3.1.2 Global Predictive Presymptomatic Testing Revenue Market Share by Players (2020-2025)
3.2 Global Predictive Presymptomatic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Predictive Presymptomatic Testing Revenue
3.4 Global Predictive Presymptomatic Testing Market Concentration Ratio
3.4.1 Global Predictive Presymptomatic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Predictive Presymptomatic Testing Revenue in 2024
3.5 Global Key Players of Predictive Presymptomatic Testing Head office and Area Served
3.6 Global Key Players of Predictive Presymptomatic Testing, Product and Application
3.7 Global Key Players of Predictive Presymptomatic Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Predictive Presymptomatic Testing Breakdown Data by Type
4.1 Global Predictive Presymptomatic Testing Historic Market Size by Type (2020-2025)
4.2 Global Predictive Presymptomatic Testing Forecasted Market Size by Type (2026-2031)
5 Predictive Presymptomatic Testing Breakdown Data by Application
5.1 Global Predictive Presymptomatic Testing Historic Market Size by Application (2020-2025)
5.2 Global Predictive Presymptomatic Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Predictive Presymptomatic Testing Market Size (2020-2031)
6.2 North America Predictive Presymptomatic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Predictive Presymptomatic Testing Market Size by Country (2020-2025)
6.4 North America Predictive Presymptomatic Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Predictive Presymptomatic Testing Market Size (2020-2031)
7.2 Europe Predictive Presymptomatic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Predictive Presymptomatic Testing Market Size by Country (2020-2025)
7.4 Europe Predictive Presymptomatic Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Predictive Presymptomatic Testing Market Size (2020-2031)
8.2 Asia-Pacific Predictive Presymptomatic Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Predictive Presymptomatic Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Predictive Presymptomatic Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Predictive Presymptomatic Testing Market Size (2020-2031)
9.2 Latin America Predictive Presymptomatic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Predictive Presymptomatic Testing Market Size by Country (2020-2025)
9.4 Latin America Predictive Presymptomatic Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Predictive Presymptomatic Testing Market Size (2020-2031)
10.2 Middle East & Africa Predictive Presymptomatic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Predictive Presymptomatic Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Predictive Presymptomatic Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 23andMe, Inc.
11.1.1 23andMe, Inc. Company Details
11.1.2 23andMe, Inc. Business Overview
11.1.3 23andMe, Inc. Predictive Presymptomatic Testing Introduction
11.1.4 23andMe, Inc. Revenue in Predictive Presymptomatic Testing Business (2020-2025)
11.1.5 23andMe, Inc. Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Predictive Presymptomatic Testing Introduction
11.2.4 Abbott Laboratories Revenue in Predictive Presymptomatic Testing Business (2020-2025)
11.2.5 Abbott Laboratories Recent Development
11.3 Bayer HealthCare AG
11.3.1 Bayer HealthCare AG Company Details
11.3.2 Bayer HealthCare AG Business Overview
11.3.3 Bayer HealthCare AG Predictive Presymptomatic Testing Introduction
11.3.4 Bayer HealthCare AG Revenue in Predictive Presymptomatic Testing Business (2020-2025)
11.3.5 Bayer HealthCare AG Recent Development
11.4 Biocartis SA
11.4.1 Biocartis SA Company Details
11.4.2 Biocartis SA Business Overview
11.4.3 Biocartis SA Predictive Presymptomatic Testing Introduction
11.4.4 Biocartis SA Revenue in Predictive Presymptomatic Testing Business (2020-2025)
11.4.5 Biocartis SA Recent Development
11.5 BioHelix Corporation
11.5.1 BioHelix Corporation Company Details
11.5.2 BioHelix Corporation Business Overview
11.5.3 BioHelix Corporation Predictive Presymptomatic Testing Introduction
11.5.4 BioHelix Corporation Revenue in Predictive Presymptomatic Testing Business (2020-2025)
11.5.5 BioHelix Corporation Recent Development
11.6 bioMerieux S.A.
11.6.1 bioMerieux S.A. Company Details
11.6.2 bioMerieux S.A. Business Overview
11.6.3 bioMerieux S.A. Predictive Presymptomatic Testing Introduction
11.6.4 bioMerieux S.A. Revenue in Predictive Presymptomatic Testing Business (2020-2025)
11.6.5 bioMerieux S.A. Recent Development
11.7 Celera Corporation (Quest Diagnostics)
11.7.1 Celera Corporation (Quest Diagnostics) Company Details
11.7.2 Celera Corporation (Quest Diagnostics) Business Overview
11.7.3 Celera Corporation (Quest Diagnostics) Predictive Presymptomatic Testing Introduction
11.7.4 Celera Corporation (Quest Diagnostics) Revenue in Predictive Presymptomatic Testing Business (2020-2025)
11.7.5 Celera Corporation (Quest Diagnostics) Recent Development
11.8 Cepheid (Danaher)
11.8.1 Cepheid (Danaher) Company Details
11.8.2 Cepheid (Danaher) Business Overview
11.8.3 Cepheid (Danaher) Predictive Presymptomatic Testing Introduction
11.8.4 Cepheid (Danaher) Revenue in Predictive Presymptomatic Testing Business (2020-2025)
11.8.5 Cepheid (Danaher) Recent Development
11.9 Daan Diagnostics Ltd.
11.9.1 Daan Diagnostics Ltd. Company Details
11.9.2 Daan Diagnostics Ltd. Business Overview
11.9.3 Daan Diagnostics Ltd. Predictive Presymptomatic Testing Introduction
11.9.4 Daan Diagnostics Ltd. Revenue in Predictive Presymptomatic Testing Business (2020-2025)
11.9.5 Daan Diagnostics Ltd. Recent Development
11.10 EKF Diagnostics Holdings plc
11.10.1 EKF Diagnostics Holdings plc Company Details
11.10.2 EKF Diagnostics Holdings plc Business Overview
11.10.3 EKF Diagnostics Holdings plc Predictive Presymptomatic Testing Introduction
11.10.4 EKF Diagnostics Holdings plc Revenue in Predictive Presymptomatic Testing Business (2020-2025)
11.10.5 EKF Diagnostics Holdings plc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Predictive Presymptomatic Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Molecular Testing
1.2.3 Cytogenic Testing
1.2.4 Biochemical Testing
1.3 Market by Application
1.3.1 Global Predictive Presymptomatic Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Breast and Ovarian Cancer
1.3.3 Colorectal Cancer
1.3.4 Alzheimer's Disease
1.3.5 Multiple Endocrine Neoplasia Type 2
1.3.6 Haemochromatosis
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Predictive Presymptomatic Testing Market Perspective (2020-2031)
2.2 Global Predictive Presymptomatic Testing Growth Trends by Region
2.2.1 Global Predictive Presymptomatic Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Predictive Presymptomatic Testing Historic Market Size by Region (2020-2025)
2.2.3 Predictive Presymptomatic Testing Forecasted Market Size by Region (2026-2031)
2.3 Predictive Presymptomatic Testing Market Dynamics
2.3.1 Predictive Presymptomatic Testing Industry Trends
2.3.2 Predictive Presymptomatic Testing Market Drivers
2.3.3 Predictive Presymptomatic Testing Market Challenges
2.3.4 Predictive Presymptomatic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Predictive Presymptomatic Testing Players by Revenue
3.1.1 Global Top Predictive Presymptomatic Testing Players by Revenue (2020-2025)
3.1.2 Global Predictive Presymptomatic Testing Revenue Market Share by Players (2020-2025)
3.2 Global Predictive Presymptomatic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Predictive Presymptomatic Testing Revenue
3.4 Global Predictive Presymptomatic Testing Market Concentration Ratio
3.4.1 Global Predictive Presymptomatic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Predictive Presymptomatic Testing Revenue in 2024
3.5 Global Key Players of Predictive Presymptomatic Testing Head office and Area Served
3.6 Global Key Players of Predictive Presymptomatic Testing, Product and Application
3.7 Global Key Players of Predictive Presymptomatic Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Predictive Presymptomatic Testing Breakdown Data by Type
4.1 Global Predictive Presymptomatic Testing Historic Market Size by Type (2020-2025)
4.2 Global Predictive Presymptomatic Testing Forecasted Market Size by Type (2026-2031)
5 Predictive Presymptomatic Testing Breakdown Data by Application
5.1 Global Predictive Presymptomatic Testing Historic Market Size by Application (2020-2025)
5.2 Global Predictive Presymptomatic Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Predictive Presymptomatic Testing Market Size (2020-2031)
6.2 North America Predictive Presymptomatic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Predictive Presymptomatic Testing Market Size by Country (2020-2025)
6.4 North America Predictive Presymptomatic Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Predictive Presymptomatic Testing Market Size (2020-2031)
7.2 Europe Predictive Presymptomatic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Predictive Presymptomatic Testing Market Size by Country (2020-2025)
7.4 Europe Predictive Presymptomatic Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Predictive Presymptomatic Testing Market Size (2020-2031)
8.2 Asia-Pacific Predictive Presymptomatic Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Predictive Presymptomatic Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Predictive Presymptomatic Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Predictive Presymptomatic Testing Market Size (2020-2031)
9.2 Latin America Predictive Presymptomatic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Predictive Presymptomatic Testing Market Size by Country (2020-2025)
9.4 Latin America Predictive Presymptomatic Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Predictive Presymptomatic Testing Market Size (2020-2031)
10.2 Middle East & Africa Predictive Presymptomatic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Predictive Presymptomatic Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Predictive Presymptomatic Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 23andMe, Inc.
11.1.1 23andMe, Inc. Company Details
11.1.2 23andMe, Inc. Business Overview
11.1.3 23andMe, Inc. Predictive Presymptomatic Testing Introduction
11.1.4 23andMe, Inc. Revenue in Predictive Presymptomatic Testing Business (2020-2025)
11.1.5 23andMe, Inc. Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Predictive Presymptomatic Testing Introduction
11.2.4 Abbott Laboratories Revenue in Predictive Presymptomatic Testing Business (2020-2025)
11.2.5 Abbott Laboratories Recent Development
11.3 Bayer HealthCare AG
11.3.1 Bayer HealthCare AG Company Details
11.3.2 Bayer HealthCare AG Business Overview
11.3.3 Bayer HealthCare AG Predictive Presymptomatic Testing Introduction
11.3.4 Bayer HealthCare AG Revenue in Predictive Presymptomatic Testing Business (2020-2025)
11.3.5 Bayer HealthCare AG Recent Development
11.4 Biocartis SA
11.4.1 Biocartis SA Company Details
11.4.2 Biocartis SA Business Overview
11.4.3 Biocartis SA Predictive Presymptomatic Testing Introduction
11.4.4 Biocartis SA Revenue in Predictive Presymptomatic Testing Business (2020-2025)
11.4.5 Biocartis SA Recent Development
11.5 BioHelix Corporation
11.5.1 BioHelix Corporation Company Details
11.5.2 BioHelix Corporation Business Overview
11.5.3 BioHelix Corporation Predictive Presymptomatic Testing Introduction
11.5.4 BioHelix Corporation Revenue in Predictive Presymptomatic Testing Business (2020-2025)
11.5.5 BioHelix Corporation Recent Development
11.6 bioMerieux S.A.
11.6.1 bioMerieux S.A. Company Details
11.6.2 bioMerieux S.A. Business Overview
11.6.3 bioMerieux S.A. Predictive Presymptomatic Testing Introduction
11.6.4 bioMerieux S.A. Revenue in Predictive Presymptomatic Testing Business (2020-2025)
11.6.5 bioMerieux S.A. Recent Development
11.7 Celera Corporation (Quest Diagnostics)
11.7.1 Celera Corporation (Quest Diagnostics) Company Details
11.7.2 Celera Corporation (Quest Diagnostics) Business Overview
11.7.3 Celera Corporation (Quest Diagnostics) Predictive Presymptomatic Testing Introduction
11.7.4 Celera Corporation (Quest Diagnostics) Revenue in Predictive Presymptomatic Testing Business (2020-2025)
11.7.5 Celera Corporation (Quest Diagnostics) Recent Development
11.8 Cepheid (Danaher)
11.8.1 Cepheid (Danaher) Company Details
11.8.2 Cepheid (Danaher) Business Overview
11.8.3 Cepheid (Danaher) Predictive Presymptomatic Testing Introduction
11.8.4 Cepheid (Danaher) Revenue in Predictive Presymptomatic Testing Business (2020-2025)
11.8.5 Cepheid (Danaher) Recent Development
11.9 Daan Diagnostics Ltd.
11.9.1 Daan Diagnostics Ltd. Company Details
11.9.2 Daan Diagnostics Ltd. Business Overview
11.9.3 Daan Diagnostics Ltd. Predictive Presymptomatic Testing Introduction
11.9.4 Daan Diagnostics Ltd. Revenue in Predictive Presymptomatic Testing Business (2020-2025)
11.9.5 Daan Diagnostics Ltd. Recent Development
11.10 EKF Diagnostics Holdings plc
11.10.1 EKF Diagnostics Holdings plc Company Details
11.10.2 EKF Diagnostics Holdings plc Business Overview
11.10.3 EKF Diagnostics Holdings plc Predictive Presymptomatic Testing Introduction
11.10.4 EKF Diagnostics Holdings plc Revenue in Predictive Presymptomatic Testing Business (2020-2025)
11.10.5 EKF Diagnostics Holdings plc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Predictive Presymptomatic Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Molecular Testing
Table 3. Key Players of Cytogenic Testing
Table 4. Key Players of Biochemical Testing
Table 5. Global Predictive Presymptomatic Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Predictive Presymptomatic Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Predictive Presymptomatic Testing Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Predictive Presymptomatic Testing Market Share by Region (2020-2025)
Table 9. Global Predictive Presymptomatic Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Predictive Presymptomatic Testing Market Share by Region (2026-2031)
Table 11. Predictive Presymptomatic Testing Market Trends
Table 12. Predictive Presymptomatic Testing Market Drivers
Table 13. Predictive Presymptomatic Testing Market Challenges
Table 14. Predictive Presymptomatic Testing Market Restraints
Table 15. Global Predictive Presymptomatic Testing Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Predictive Presymptomatic Testing Market Share by Players (2020-2025)
Table 17. Global Top Predictive Presymptomatic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Predictive Presymptomatic Testing as of 2024)
Table 18. Ranking of Global Top Predictive Presymptomatic Testing Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Predictive Presymptomatic Testing Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Predictive Presymptomatic Testing, Headquarters and Area Served
Table 21. Global Key Players of Predictive Presymptomatic Testing, Product and Application
Table 22. Global Key Players of Predictive Presymptomatic Testing, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Predictive Presymptomatic Testing Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Predictive Presymptomatic Testing Revenue Market Share by Type (2020-2025)
Table 26. Global Predictive Presymptomatic Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Predictive Presymptomatic Testing Revenue Market Share by Type (2026-2031)
Table 28. Global Predictive Presymptomatic Testing Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Predictive Presymptomatic Testing Revenue Market Share by Application (2020-2025)
Table 30. Global Predictive Presymptomatic Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Predictive Presymptomatic Testing Revenue Market Share by Application (2026-2031)
Table 32. North America Predictive Presymptomatic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Predictive Presymptomatic Testing Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Predictive Presymptomatic Testing Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Predictive Presymptomatic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Predictive Presymptomatic Testing Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Predictive Presymptomatic Testing Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Predictive Presymptomatic Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Predictive Presymptomatic Testing Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Predictive Presymptomatic Testing Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Predictive Presymptomatic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Predictive Presymptomatic Testing Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Predictive Presymptomatic Testing Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Predictive Presymptomatic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Predictive Presymptomatic Testing Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Predictive Presymptomatic Testing Market Size by Country (2026-2031) & (US$ Million)
Table 47. 23andMe, Inc. Company Details
Table 48. 23andMe, Inc. Business Overview
Table 49. 23andMe, Inc. Predictive Presymptomatic Testing Product
Table 50. 23andMe, Inc. Revenue in Predictive Presymptomatic Testing Business (2020-2025) & (US$ Million)
Table 51. 23andMe, Inc. Recent Development
Table 52. Abbott Laboratories Company Details
Table 53. Abbott Laboratories Business Overview
Table 54. Abbott Laboratories Predictive Presymptomatic Testing Product
Table 55. Abbott Laboratories Revenue in Predictive Presymptomatic Testing Business (2020-2025) & (US$ Million)
Table 56. Abbott Laboratories Recent Development
Table 57. Bayer HealthCare AG Company Details
Table 58. Bayer HealthCare AG Business Overview
Table 59. Bayer HealthCare AG Predictive Presymptomatic Testing Product
Table 60. Bayer HealthCare AG Revenue in Predictive Presymptomatic Testing Business (2020-2025) & (US$ Million)
Table 61. Bayer HealthCare AG Recent Development
Table 62. Biocartis SA Company Details
Table 63. Biocartis SA Business Overview
Table 64. Biocartis SA Predictive Presymptomatic Testing Product
Table 65. Biocartis SA Revenue in Predictive Presymptomatic Testing Business (2020-2025) & (US$ Million)
Table 66. Biocartis SA Recent Development
Table 67. BioHelix Corporation Company Details
Table 68. BioHelix Corporation Business Overview
Table 69. BioHelix Corporation Predictive Presymptomatic Testing Product
Table 70. BioHelix Corporation Revenue in Predictive Presymptomatic Testing Business (2020-2025) & (US$ Million)
Table 71. BioHelix Corporation Recent Development
Table 72. bioMerieux S.A. Company Details
Table 73. bioMerieux S.A. Business Overview
Table 74. bioMerieux S.A. Predictive Presymptomatic Testing Product
Table 75. bioMerieux S.A. Revenue in Predictive Presymptomatic Testing Business (2020-2025) & (US$ Million)
Table 76. bioMerieux S.A. Recent Development
Table 77. Celera Corporation (Quest Diagnostics) Company Details
Table 78. Celera Corporation (Quest Diagnostics) Business Overview
Table 79. Celera Corporation (Quest Diagnostics) Predictive Presymptomatic Testing Product
Table 80. Celera Corporation (Quest Diagnostics) Revenue in Predictive Presymptomatic Testing Business (2020-2025) & (US$ Million)
Table 81. Celera Corporation (Quest Diagnostics) Recent Development
Table 82. Cepheid (Danaher) Company Details
Table 83. Cepheid (Danaher) Business Overview
Table 84. Cepheid (Danaher) Predictive Presymptomatic Testing Product
Table 85. Cepheid (Danaher) Revenue in Predictive Presymptomatic Testing Business (2020-2025) & (US$ Million)
Table 86. Cepheid (Danaher) Recent Development
Table 87. Daan Diagnostics Ltd. Company Details
Table 88. Daan Diagnostics Ltd. Business Overview
Table 89. Daan Diagnostics Ltd. Predictive Presymptomatic Testing Product
Table 90. Daan Diagnostics Ltd. Revenue in Predictive Presymptomatic Testing Business (2020-2025) & (US$ Million)
Table 91. Daan Diagnostics Ltd. Recent Development
Table 92. EKF Diagnostics Holdings plc Company Details
Table 93. EKF Diagnostics Holdings plc Business Overview
Table 94. EKF Diagnostics Holdings plc Predictive Presymptomatic Testing Product
Table 95. EKF Diagnostics Holdings plc Revenue in Predictive Presymptomatic Testing Business (2020-2025) & (US$ Million)
Table 96. EKF Diagnostics Holdings plc Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
Table 100. Authors List of This Report
List of Figures
Figure 1. Predictive Presymptomatic Testing Picture
Figure 2. Global Predictive Presymptomatic Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Predictive Presymptomatic Testing Market Share by Type: 2024 VS 2031
Figure 4. Molecular Testing Features
Figure 5. Cytogenic Testing Features
Figure 6. Biochemical Testing Features
Figure 7. Global Predictive Presymptomatic Testing Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Predictive Presymptomatic Testing Market Share by Application: 2024 VS 2031
Figure 9. Breast and Ovarian Cancer Case Studies
Figure 10. Colorectal Cancer Case Studies
Figure 11. Alzheimer's Disease Case Studies
Figure 12. Multiple Endocrine Neoplasia Type 2 Case Studies
Figure 13. Haemochromatosis Case Studies
Figure 14. Predictive Presymptomatic Testing Report Years Considered
Figure 15. Global Predictive Presymptomatic Testing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Predictive Presymptomatic Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Predictive Presymptomatic Testing Market Share by Region: 2024 VS 2031
Figure 18. Global Predictive Presymptomatic Testing Market Share by Players in 2024
Figure 19. Global Top Predictive Presymptomatic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Predictive Presymptomatic Testing as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Predictive Presymptomatic Testing Revenue in 2024
Figure 21. North America Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Predictive Presymptomatic Testing Market Share by Country (2020-2031)
Figure 23. United States Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Predictive Presymptomatic Testing Market Share by Country (2020-2031)
Figure 27. Germany Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Predictive Presymptomatic Testing Market Share by Region (2020-2031)
Figure 35. China Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Predictive Presymptomatic Testing Market Share by Country (2020-2031)
Figure 43. Mexico Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Predictive Presymptomatic Testing Market Share by Country (2020-2031)
Figure 47. Turkey Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. 23andMe, Inc. Revenue Growth Rate in Predictive Presymptomatic Testing Business (2020-2025)
Figure 51. Abbott Laboratories Revenue Growth Rate in Predictive Presymptomatic Testing Business (2020-2025)
Figure 52. Bayer HealthCare AG Revenue Growth Rate in Predictive Presymptomatic Testing Business (2020-2025)
Figure 53. Biocartis SA Revenue Growth Rate in Predictive Presymptomatic Testing Business (2020-2025)
Figure 54. BioHelix Corporation Revenue Growth Rate in Predictive Presymptomatic Testing Business (2020-2025)
Figure 55. bioMerieux S.A. Revenue Growth Rate in Predictive Presymptomatic Testing Business (2020-2025)
Figure 56. Celera Corporation (Quest Diagnostics) Revenue Growth Rate in Predictive Presymptomatic Testing Business (2020-2025)
Figure 57. Cepheid (Danaher) Revenue Growth Rate in Predictive Presymptomatic Testing Business (2020-2025)
Figure 58. Daan Diagnostics Ltd. Revenue Growth Rate in Predictive Presymptomatic Testing Business (2020-2025)
Figure 59. EKF Diagnostics Holdings plc Revenue Growth Rate in Predictive Presymptomatic Testing Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Predictive Presymptomatic Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Molecular Testing
Table 3. Key Players of Cytogenic Testing
Table 4. Key Players of Biochemical Testing
Table 5. Global Predictive Presymptomatic Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Predictive Presymptomatic Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Predictive Presymptomatic Testing Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Predictive Presymptomatic Testing Market Share by Region (2020-2025)
Table 9. Global Predictive Presymptomatic Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Predictive Presymptomatic Testing Market Share by Region (2026-2031)
Table 11. Predictive Presymptomatic Testing Market Trends
Table 12. Predictive Presymptomatic Testing Market Drivers
Table 13. Predictive Presymptomatic Testing Market Challenges
Table 14. Predictive Presymptomatic Testing Market Restraints
Table 15. Global Predictive Presymptomatic Testing Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Predictive Presymptomatic Testing Market Share by Players (2020-2025)
Table 17. Global Top Predictive Presymptomatic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Predictive Presymptomatic Testing as of 2024)
Table 18. Ranking of Global Top Predictive Presymptomatic Testing Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Predictive Presymptomatic Testing Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Predictive Presymptomatic Testing, Headquarters and Area Served
Table 21. Global Key Players of Predictive Presymptomatic Testing, Product and Application
Table 22. Global Key Players of Predictive Presymptomatic Testing, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Predictive Presymptomatic Testing Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Predictive Presymptomatic Testing Revenue Market Share by Type (2020-2025)
Table 26. Global Predictive Presymptomatic Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Predictive Presymptomatic Testing Revenue Market Share by Type (2026-2031)
Table 28. Global Predictive Presymptomatic Testing Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Predictive Presymptomatic Testing Revenue Market Share by Application (2020-2025)
Table 30. Global Predictive Presymptomatic Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Predictive Presymptomatic Testing Revenue Market Share by Application (2026-2031)
Table 32. North America Predictive Presymptomatic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Predictive Presymptomatic Testing Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Predictive Presymptomatic Testing Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Predictive Presymptomatic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Predictive Presymptomatic Testing Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Predictive Presymptomatic Testing Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Predictive Presymptomatic Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Predictive Presymptomatic Testing Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Predictive Presymptomatic Testing Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Predictive Presymptomatic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Predictive Presymptomatic Testing Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Predictive Presymptomatic Testing Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Predictive Presymptomatic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Predictive Presymptomatic Testing Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Predictive Presymptomatic Testing Market Size by Country (2026-2031) & (US$ Million)
Table 47. 23andMe, Inc. Company Details
Table 48. 23andMe, Inc. Business Overview
Table 49. 23andMe, Inc. Predictive Presymptomatic Testing Product
Table 50. 23andMe, Inc. Revenue in Predictive Presymptomatic Testing Business (2020-2025) & (US$ Million)
Table 51. 23andMe, Inc. Recent Development
Table 52. Abbott Laboratories Company Details
Table 53. Abbott Laboratories Business Overview
Table 54. Abbott Laboratories Predictive Presymptomatic Testing Product
Table 55. Abbott Laboratories Revenue in Predictive Presymptomatic Testing Business (2020-2025) & (US$ Million)
Table 56. Abbott Laboratories Recent Development
Table 57. Bayer HealthCare AG Company Details
Table 58. Bayer HealthCare AG Business Overview
Table 59. Bayer HealthCare AG Predictive Presymptomatic Testing Product
Table 60. Bayer HealthCare AG Revenue in Predictive Presymptomatic Testing Business (2020-2025) & (US$ Million)
Table 61. Bayer HealthCare AG Recent Development
Table 62. Biocartis SA Company Details
Table 63. Biocartis SA Business Overview
Table 64. Biocartis SA Predictive Presymptomatic Testing Product
Table 65. Biocartis SA Revenue in Predictive Presymptomatic Testing Business (2020-2025) & (US$ Million)
Table 66. Biocartis SA Recent Development
Table 67. BioHelix Corporation Company Details
Table 68. BioHelix Corporation Business Overview
Table 69. BioHelix Corporation Predictive Presymptomatic Testing Product
Table 70. BioHelix Corporation Revenue in Predictive Presymptomatic Testing Business (2020-2025) & (US$ Million)
Table 71. BioHelix Corporation Recent Development
Table 72. bioMerieux S.A. Company Details
Table 73. bioMerieux S.A. Business Overview
Table 74. bioMerieux S.A. Predictive Presymptomatic Testing Product
Table 75. bioMerieux S.A. Revenue in Predictive Presymptomatic Testing Business (2020-2025) & (US$ Million)
Table 76. bioMerieux S.A. Recent Development
Table 77. Celera Corporation (Quest Diagnostics) Company Details
Table 78. Celera Corporation (Quest Diagnostics) Business Overview
Table 79. Celera Corporation (Quest Diagnostics) Predictive Presymptomatic Testing Product
Table 80. Celera Corporation (Quest Diagnostics) Revenue in Predictive Presymptomatic Testing Business (2020-2025) & (US$ Million)
Table 81. Celera Corporation (Quest Diagnostics) Recent Development
Table 82. Cepheid (Danaher) Company Details
Table 83. Cepheid (Danaher) Business Overview
Table 84. Cepheid (Danaher) Predictive Presymptomatic Testing Product
Table 85. Cepheid (Danaher) Revenue in Predictive Presymptomatic Testing Business (2020-2025) & (US$ Million)
Table 86. Cepheid (Danaher) Recent Development
Table 87. Daan Diagnostics Ltd. Company Details
Table 88. Daan Diagnostics Ltd. Business Overview
Table 89. Daan Diagnostics Ltd. Predictive Presymptomatic Testing Product
Table 90. Daan Diagnostics Ltd. Revenue in Predictive Presymptomatic Testing Business (2020-2025) & (US$ Million)
Table 91. Daan Diagnostics Ltd. Recent Development
Table 92. EKF Diagnostics Holdings plc Company Details
Table 93. EKF Diagnostics Holdings plc Business Overview
Table 94. EKF Diagnostics Holdings plc Predictive Presymptomatic Testing Product
Table 95. EKF Diagnostics Holdings plc Revenue in Predictive Presymptomatic Testing Business (2020-2025) & (US$ Million)
Table 96. EKF Diagnostics Holdings plc Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
Table 100. Authors List of This Report
List of Figures
Figure 1. Predictive Presymptomatic Testing Picture
Figure 2. Global Predictive Presymptomatic Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Predictive Presymptomatic Testing Market Share by Type: 2024 VS 2031
Figure 4. Molecular Testing Features
Figure 5. Cytogenic Testing Features
Figure 6. Biochemical Testing Features
Figure 7. Global Predictive Presymptomatic Testing Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Predictive Presymptomatic Testing Market Share by Application: 2024 VS 2031
Figure 9. Breast and Ovarian Cancer Case Studies
Figure 10. Colorectal Cancer Case Studies
Figure 11. Alzheimer's Disease Case Studies
Figure 12. Multiple Endocrine Neoplasia Type 2 Case Studies
Figure 13. Haemochromatosis Case Studies
Figure 14. Predictive Presymptomatic Testing Report Years Considered
Figure 15. Global Predictive Presymptomatic Testing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Predictive Presymptomatic Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Predictive Presymptomatic Testing Market Share by Region: 2024 VS 2031
Figure 18. Global Predictive Presymptomatic Testing Market Share by Players in 2024
Figure 19. Global Top Predictive Presymptomatic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Predictive Presymptomatic Testing as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Predictive Presymptomatic Testing Revenue in 2024
Figure 21. North America Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Predictive Presymptomatic Testing Market Share by Country (2020-2031)
Figure 23. United States Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Predictive Presymptomatic Testing Market Share by Country (2020-2031)
Figure 27. Germany Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Predictive Presymptomatic Testing Market Share by Region (2020-2031)
Figure 35. China Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Predictive Presymptomatic Testing Market Share by Country (2020-2031)
Figure 43. Mexico Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Predictive Presymptomatic Testing Market Share by Country (2020-2031)
Figure 47. Turkey Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Predictive Presymptomatic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. 23andMe, Inc. Revenue Growth Rate in Predictive Presymptomatic Testing Business (2020-2025)
Figure 51. Abbott Laboratories Revenue Growth Rate in Predictive Presymptomatic Testing Business (2020-2025)
Figure 52. Bayer HealthCare AG Revenue Growth Rate in Predictive Presymptomatic Testing Business (2020-2025)
Figure 53. Biocartis SA Revenue Growth Rate in Predictive Presymptomatic Testing Business (2020-2025)
Figure 54. BioHelix Corporation Revenue Growth Rate in Predictive Presymptomatic Testing Business (2020-2025)
Figure 55. bioMerieux S.A. Revenue Growth Rate in Predictive Presymptomatic Testing Business (2020-2025)
Figure 56. Celera Corporation (Quest Diagnostics) Revenue Growth Rate in Predictive Presymptomatic Testing Business (2020-2025)
Figure 57. Cepheid (Danaher) Revenue Growth Rate in Predictive Presymptomatic Testing Business (2020-2025)
Figure 58. Daan Diagnostics Ltd. Revenue Growth Rate in Predictive Presymptomatic Testing Business (2020-2025)
Figure 59. EKF Diagnostics Holdings plc Revenue Growth Rate in Predictive Presymptomatic Testing Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232